This activity explores the evolving landscape of lipoprotein cholesterol (LDL-C) management in patients with atherosclerotic cardiovascular disease (ASCVD).
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.5 credits
MOC types
ABS — Accredited CMEUp to 0.5 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- One Financial Center, 13th Floor
Pricing
100% of listed courses are free
18 of 18 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedFeb 26, 2026
-
Last day to claim creditFeb 26, 2027 4 months left
-
Vindico Medical Education, LLC Advancing Exudative Retinal Disease Management Through Tyrosine Kinase Inhibition
-
Paradigm Medical Communications, LLC The Science and Art of Retina: Exploring the Role of Ang-2 and VEGF Inhibition Across Common Clinical Scenarios
-
Global Learning Collaborative Retina Rumble: Debating Modern Treatment Options
